Metabolic syndrome in premenopausal and postmenopausal women with type 2 diabetes: loss of protective effects of premenopausal status

Journal of Diabetes & Metabolic Disorders

Alireza Esteghamati¹  Afsaneh Morteza¹  Arash Aghajani-Nargesi¹  Mehrdad Larry¹  Mehrnaz Imani¹  Manouchehr Nakhjavani¹ 

[1] Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran

关键词: Cardiovascular disease;    Women;    Menopause;    Metabolic syndrome;   

Others  :  1136048
DOI  :  10.1186/s40200-014-0102-5

 received in 2013-11-04, accepted in 2014-10-12,  发布年份 2014

【 摘 要 】

Background

Diabetes is probably responsible for worsening of metabolic syndrome (MetS)components. The aim of the present study was to compare the components of MetS between premenopausal and postmenopausal women with type 2 diabetes (T2DM).

Method

In this cross sectional study, we studied 639 women with T2DM that were divided in pre-menopausal (n = 221) and post-menopausal (n = 418) group. They were selected from participants of a diabetes clinic and assessed for MetS and its components. All MetS components were evaluated to follow age and duration of diabetes adjusted according to the ATP III criteria.

Results

The mean ages of pre-menopausal and post-menopausal were 43.33 ± 0.47 and 60.35 ± 0.38 years, respectively. MetS was defined for 88.3% of total subjects (87.5% and 87.7% in pre-menopausal and post-menopausal women with T2DM respectively). Systolic blood pressure (SBP) and waist circumference (WC) were significantly higher in post-menopausal women with T2DM in comparison with pre-menopausal ones. There were no significant differences in triglyceride (T.G) level, diastolic blood pressure (DBP) and high density lipoprotein cholesterol (HDL-C) between the two groups. Myocardial infarction (MI) occurred in 1% total subjects (1.3% and 1.8%) in pre-menopausal and post-menopausal women with T2DM, respectively (p = 0.21).

Conclusion

Worsening of MetS and its components except for SBP and waist circumference has been shown in pre-menopausal women with T2DM similar to post-menopausal ones. The observed differences may be explained by increasing age. With respect to increasing of myocardial infarction in premenopausal subjects, we suggest that diabetes can abolish the protective effects of premenopausal status for MetS and MI.

【 授权许可】

   
2014 Nakhjavani et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Ainy E, Mirmiran P, Zahedi Asl S: Prevalence of metabolic syndrome during menopausal tromsition in Tehranian women: Tehran Lipid and Glucose Study (TLGS). Maturitas 2007, 58:150-155.
• [2]Brown TM, Vaidya D, Rogers WJ: Does prevalence of metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria? J Womens Health 2008, 17:841-847.
• [3]Ana C, Basso S, Maria R: Prevalence of Metabolic syndrome and associated factors in women aged 35 to 65 years in Brazil. North Am Menopause Soc 2012, 20(4):470-476.
• [4]Qader SS, Shakir YA, Nyberg P: Sociodemographic risk factors of metabolic syndrome in middle-aged women, results from a population-based study of Swedish women, The women's Heath in the Lund Area (WHTLA) study. Climacteric 2008, 11:475-482.
• [5]Eshtiaghi R, Esteghamati A, Nakhjavani M: Menopause is an independent predictor of Metabolic syndrome in Iranian women. Maturitas 2010, 65(3):262-266.
• [6]Wing RR, Mathews KA, Kuller LH: Weight gain at the time of menopause. Arch Intern Med 1991, 151:97-102.
• [7]Third Report of the National Cholesterol Education program (NCEP) Expert panel on detection, evaluation and treatment of high blood cholesterol in adult final report Circulation 2002, 106:3143-3421.
• [8]Esteghamati AR, Ashraf H, Rashidi A: Waist cicumference cut – off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res Clin Pract 2008, 82(1):104-107.
• [9]Polotsky HN, Polotsky AJ: Metabolic Implications of Menopause. Semin Reprod Med 2010, 28(5):426-443.
• [10]Ross L, Polotsky A: Metabolic correlates of menopause: an update. Curr Opin Obstet Gyneco 2012, 24(6):402-412. l
• [11]McGillicuddy FC, De La Liera Moya M: Inflammation impairs reverse cholesterol transport in vivo. Circulation 2009, 119:1135-1145.
• [12]Nakhjavani M, Morteza A: Serum heat shock protein 70 and oxidized LDL in patients with type 2 diabetes :does sex matter? Cell Stress Chaperones 2011, 16:195-201.
• [13]Hoeg JM, Santamarina-Fojo S, Bérard AM, Cornhill JF, Herderick EE, Feldman SH, Haudenschild CC, Vaisman BL, Hoyt RF, Demosky SJ: Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc Natl Acad Sci U S A 1996, 93(21):11448-11453.
• [14]Scanu AM, Edelstein C: HDL :bridging past and present with a look at the future. FASEB J 2008, 22:4044-4054.
• [15]Harris M, Hadden W, Knowler W: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20–74 yr. Diabetes 1987, 36(4):523-534.
• [16]Zethelius B, Eeg-Olofsson K, Nilsson PM, Gudbjörnsdottir S: Blood lipids in 75 048 type 2 diabetic patients: A population-based survey from the Swedish National diabetes register. Eur J Cardiovasc Prev Rehabil 2011, 18(1):97-105.
• [17]Ushiroyama T, Sakuma K, Keda AI: The HDL2/HDL3 ratio in menopausal women. Int Gynaecol Obstet 2005, 88:303-308.
• [18]Mesch VR, Bocro LE, Siseles N: Metabolic syndrome Throughout the Menopausal transition: influence of age and menopausal status. Climacteric 2006, 9(1):40-48.
• [19]Davis SR, Castelo-Branco C, Chedraui P: Understanding weight gain at menopause. Climacteric 2012, 15(5):419-429.
• [20]Franklin SS, Gustin W, Wong ND: Hemodynamic patterns of age-related changes in blood pressure. Circulation 1997, 96:308-315.
• [21]Masding MG, Stears AJ, Burdge GC: Premenopausal Advantages in Postprandial Lipid Metabolism Are Lost in Women With Type 2 Diabetes. Diabetes Care 2003, 26:3243-3249.
• [22]Schianca GPC, Colli E, Bigliocca M: Sex difference in lipid profiles in relation to the progression of glucose abnormalities. J Diabetes 2012, 4:95-101.
• [23]Di Carli MF, Afonso L, Campisi R: Coronary vascular dysfunction in premenopausal women with diabetes mellitus. Am Heart J 2002, 144(4):711-718.
• [24]Avilés-Santa L, Salinas K, Adams-Huet B: Anthropometric feature and cardiovascular risk in young Latin Americans with type 2 diabetes mellitus. J Diabetes Complications 2006, 20(2):69-74.
• [25]Johnstone MT, Creager SJ, Scales KM: Impaired endothelium-dependent vasodilation in patients with insulin- dependent diabetes mellitus. Circulation 1993, 88(6):2510-2516.
• [26]Fulton DJR, Hodgson WC, Sikorski BW: Attenuated responses to endothelin- and KC1 and CaC12, but not noradrenaline, of aortae from rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 1991, 104:928-932.
• [27]Newton KM, Lacroix AZ, Heckbert SR: Estrogen Therapy and Risk of Cardiovasvular Events Among Women With Type 2 Diabetes. Diabetes Care 2003, 26:2810-2816.
• [28]Lamon-Fava S, Herrington DM, Horvath KV: Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status. Metabolism 2010, 59:1794-1800.
• [29]Saltiki K, Cimponeriu A, Lili K: Severity of coronary artery disease in postmenopausal diabetic women. Hormones 2008, 7(2):148-155.
• [30]Bal S: Use of hormone replacement therapy in women with diabetes. J Diab Nurs 1998, 2(2):39-42.